当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析

浙江医药

(600216)

  

流通市值:143.38亿  总市值:143.38亿
流通股本:9.62亿   总股本:9.62亿

浙江医药(600216)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润8.67亿元,每股收益0.97元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1121107.64万元,未分配利润651412.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1413552.87万元,负债292445.23万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入6,695,297,924.394,322,874,759.832,255,389,182.259,375,216,922.05
营业总成本5,638,082,321.043,511,652,540.631,778,067,510.037,934,024,498.03
其他经营收益
营业利润1,048,294,343.4761,999,585.03454,250,358.651,223,110,445.3
利润总额1,046,306,587.3758,881,420.16453,782,461.451,212,282,187.41
净利润866,731,612.94624,571,156.24385,252,415.31,020,251,510.18
每股收益
其他综合收益23,198,143.3528,286,096.289,122,458.68-7,635,393.08
综合收益总额889,929,756.29652,857,252.52394,374,873.981,012,616,117.1
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计7,121,017,781.087,114,739,673.496,811,951,484.566,584,941,036.57
非流动资产:
非流动资产合计7,014,510,876.687,087,169,849.017,184,701,913.077,210,532,069.12
资产总计14,135,528,657.7614,201,909,522.513,996,653,397.6313,795,473,105.69
流动负债:
流动负债合计2,553,967,626.422,384,856,722.852,386,933,768.282,569,444,450.43
非流动负债:
非流动负债合计370,484,655.66427,057,436.43343,753,324.51358,086,415.36
负债合计2,924,452,282.082,811,914,159.282,730,687,092.792,927,530,865.79
所有者权益(或股东权益):
归属于母公司股东权益合计11,054,845,999.6711,214,681,567.5111,067,801,751.7210,648,142,085.06
股东权益合计11,211,076,375.6811,389,995,363.2211,265,966,304.8410,867,942,239.9
负债和股东权益合计14,135,528,657.7614,201,909,522.513,996,653,397.6313,795,473,105.69
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计7,517,127,199.14,933,125,935.972,410,514,065.329,130,924,502.02
经营活动现金流出小计6,028,461,425.194,134,944,730.932,105,549,414.327,907,625,860.07
经营活动产生的现金流量净额1,488,665,773.91798,181,205.04304,964,6511,223,298,641.95
投资活动产生的现金流量:
投资活动现金流入小计1,521,591,183.19909,447,045.65472,919,982.851,211,707,968.83
投资活动现金流出小计1,764,620,085.631,036,475,006.73591,343,225.751,685,207,838.41
投资活动产生的现金流量净额-243,028,902.44-127,027,961.08-118,423,242.9-473,499,869.58
筹资活动产生的现金流量:
筹资活动现金流入小计546,577,625.82495,000,000185,000,000520,000,000
筹资活动现金流出小计914,225,923.19486,767,481.42142,771,240.27775,320,876.26
筹资活动产生的现金流量净额-367,648,297.378,232,518.5842,228,759.73-255,320,876.26
汇率变动对现金及现金等价物的影响55,426,355.6863,636,449.1822,827,650.8311,267,874.76
现金及现金等价物净增加额933,414,929.78743,022,211.72251,597,818.66505,745,770.87
期末现金及现金等价物余额2,899,000,340.842,708,607,622.782,217,183,229.721,965,585,411.06
补充资料:
现金及现金等价物的净增加额-743,022,211.72-505,745,770.87
最新报告期:2025-11-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券王彤,肖亚平1.151.551.942025-11-06
长城证券王彤,肖亚平1.161.581.702025-09-02
光大证券蔡嘉豪,赵乃迪1.021.101.192025-08-28
中金公司侯一林,裘孝锋,贾雄伟1.141.14--2025-08-26
TOP↑